Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]

• Fatma Merve Tepetam, MD,
• Şeyma Özden, MD,
• Fatma Kübra Kılıç, MD,
• Cihan Örçen, MD,
• Tuğçe Yakut, MD

Affiliations

Fatma Merve Tepetam, MD

University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, Turkey; Corresponding author. University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Basibuyuk Mahallesi, Maltepe, 34854, Istanbul, Turkey.

Şeyma Özden, MD

University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, Turkey

Fatma Kübra Kılıç, MD

University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, Turkey

Cihan Örçen, MD

University of Health Sciences, Derince Training and Research Hospital, Kocaeli, Turkey

Tuğçe Yakut, MD

University of Health Sciences, Diyarbakır Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey